Details for New Drug Application (NDA): 205564
✉ Email this page to a colleague
The generic ingredient in LEVOCETIRIZINE DIHYDROCHLORIDE is levocetirizine dihydrochloride. There are thirteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the levocetirizine dihydrochloride profile page.
Summary for 205564
Tradename: | LEVOCETIRIZINE DIHYDROCHLORIDE |
Applicant: | Macleods Pharms Ltd |
Ingredient: | levocetirizine dihydrochloride |
Patents: | 0 |
Pharmacology for NDA: 205564
Mechanism of Action | Histamine H1 Receptor Antagonists |
Suppliers and Packaging for NDA: 205564
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LEVOCETIRIZINE DIHYDROCHLORIDE | levocetirizine dihydrochloride | TABLET;ORAL | 205564 | ANDA | Macleods Pharmaceuticals Limited | 33342-200 | 33342-200-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-200-07) |
LEVOCETIRIZINE DIHYDROCHLORIDE | levocetirizine dihydrochloride | TABLET;ORAL | 205564 | ANDA | Macleods Pharmaceuticals Limited | 33342-200 | 33342-200-10 | 90 TABLET, FILM COATED in 1 BOTTLE (33342-200-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Jan 11, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription